Associated Papers
Engineered L-asparaginase variants with enhanced therapeutic properties to improve treatment of childhood acute lymphatic leukemia.
Biswas M et al.
Cancer Gene Therapy, 2025
Preclinical evaluation of engineered L-asparaginase variants to improve the treatment of Acute Lymphoblastic Leukemia.
Sengupta S et al.
Translational Oncology, 2024
In vivo stabilization of a less toxic asparaginase variant leads to a durable antitumor response in acute leukemia.
Van Trimpont M et al.
Haematologica, 2023
Select a paper to view details